The novel treatment of this peptide represents a exciting development in the management of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide629592.jaiblogs.com/69107893/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment